A Comparative Study on the Efficacy of Different Stepping-down Therapy for Childhood Asthma
Status:
Not yet recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
This study is a 24-week, randomized, parallel group comparative effectiveness study to
evaluate the risk of stepping down therapy for patients with well-controlled asthma treated
with combination Inhaled corticosteroids (ICS) and Leukotriene receptor antagonist（LTRA).